Bolt Biotherapeutics Inc. (BOLT)
0.52
0.00 (0.68%)
At close: Jan 15, 2025, 1:27 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| PE Ratio | -0.61 | -0.57 | -1.76 | -16.12 | -37.61 | -26.13 |
| PS Ratio | 5.38 | 8.48 | 145.44 | 5.04K | 5.25K | n/a |
| PB Ratio | 0.38 | 0.28 | 0.73 | -11.1 | -24.61 | -18.99 |
| P/FCF Ratio | -0.61 | -0.62 | -3.08 | -23.04 | -42.02 | -29.8 |
| P/OCF Ratio | -0.61 | -0.63 | -3.21 | -24.63 | -42.83 | -30.67 |
| OCF/S Ratio | -8.83 | -13.35 | -45.29 | -204.8 | -122.53 | n/a |
| Debt / Equity Ratio | 0.18 | 0.13 | 0.10 | -0.1 | -0.22 | -0.00 |
| Quick Ratio | 5.17 | 7.51 | 8.88 | 2.25 | 4.18 | 5.12 |
| Current Ratio | 5.17 | 7.47 | 8.87 | 2.25 | 4.15 | 5.12 |
| Asset Turnover | 0.05 | 0.03 | 0.00 | 0.00 | 0.00 | n/a |
| Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a |
| Return on Equity (ROE) | -0.61 | -0.5 | -0.42 | 0.69 | 0.65 | 0.73 |
| Return on Assets (ROA) | -0.43 | -0.38 | -0.34 | -1.55 | -0.62 | -0.73 |
| Return on Capital (ROIC) | -0.55 | -0.44 | -0.32 | -1.39 | -0.78 | -0.88 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 76.08% | 14.63% | -191.43% | -17.37K% | -11.99K% | n/a |
| Net Profit Margin | -878.58% | -1.50K% | -8.29K% | -31.29K% | -13.96K% | n/a |
| Pretax Profit Margin | -878.58% | -1.54K% | -7.82K% | -26.29K% | -14.18K% | n/a |
| Operating Profit Margin | -967.45% | -1.58K% | -7.36K% | -21.29K% | -14.40K% | n/a |
| FCF Margin | -885.36% | -1.37K% | -4.71K% | -21.89K% | -12.49K% | n/a |
| EBITDA Margin | -943.91% | -1.55K% | -7.27K% | -21.03K% | -14.25K% | n/a |